PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
Prostate cancer is one of the most common cancers among men worldwide. It develops in the prostate gland, a small organ that plays a crucial role in male reproductive health. While some prostate cancers grow slowly and may not cause significant harm, others can be aggressive and life-threatening if left untreated. Understanding the risk factors, symptoms, diagnosis, and treatment options can help in early detection and better management of the disease.
Prostate cancer has been recognized for centuries, but it was not until the 19th century that medical advancements allowed for its proper identification. The first recorded case dates back to the 1850s when surgical interventions were explored. By the mid-20th century, researchers developed the Prostate-Specific Antigen (PSA) test, a major breakthrough in early detection. Today, modern treatments, including robotic-assisted surgery and precision radiotherapy, have significantly improved patient outcomes.
The exact cause of prostate cancer remains unknown, but several risk factors increase the likelihood of developing the disease:
Prostate cancer often develops without noticeable symptoms in its early stages. As the disease progresses, common symptoms include:
Since early-stage prostate cancer may not show any symptoms, regular screening is essential for early detection.
Early diagnosis significantly improves treatment success rates and survival outcomes.
The choice of treatment depends on the stage, aggressiveness, and overall health of the patient. The primary treatment options include:
Early detection allows for a broader range of treatment options with better survival rates.
New advancements in precision medicine and immunotherapy are improving outcomes even for advanced cases.
While prostate cancer cannot always be prevented, adopting a healthy lifestyle can reduce the risk:
Prostate cancer remains a major health concern for men worldwide, but early detection and advanced treatment options have significantly improved survival rates. Regular screenings, lifestyle modifications, and awareness can help reduce the risk and improve outcomes.
WhatsApp us